{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:29Z","timestamp":1793043089833,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004769","name":"University of Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaccao.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:21:12Z","timestamp":1757629272000},"page":"751-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Paolo","family":"Milani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Damiano","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bellofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Nuvolone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Basset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mussinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ciardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Caminito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Ghazi Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadjavad","family":"Sadrzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Benigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bosoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Barassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Foli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Perlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaccao.2025.07.012_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/13506129.2024.2374904","article-title":"Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis","volume":"31","author":"Milani","year":"2024","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.jaccao.2025.07.012_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.jaccao.2025.07.012_bib3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.jaccao.2025.07.012_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.11687","article-title":"Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis","volume":"93","author":"Bochtler","year":"2008","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jaccao.2025.07.012_bib5","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1515\/cclm-2013-0361","article-title":"Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis","volume":"51","author":"Mollee","year":"2013","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1016\/j.jaccao.2025.07.012_bib6","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1515\/cclm-2016-1024","article-title":"Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays","volume":"55","author":"Palladini","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.jaccao.2025.07.012_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13506120500352339","article-title":"Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis","volume":"12","author":"Akar","year":"2005","journal-title":"Amyloid"},{"issue":"36","key":"10.1016\/j.jaccao.2025.07.012_bib8","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2025.07.012_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2020.1868810","article-title":"Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis","volume":"28","author":"Palladini","year":"2021","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.jaccao.2025.07.012_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2017-02-767467","article-title":"Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome","volume":"130","author":"Milani","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaccao.2025.07.012_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2017-02-767475","article-title":"AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis","volume":"130","author":"Dittrich","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaccao.2025.07.012_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-020-00355-6","article-title":"Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy","volume":"10","author":"Milani","year":"2020","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.jaccao.2025.07.012_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41408-020-00354-7","article-title":"Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis","volume":"10","author":"Sarosiek","year":"2020","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.jaccao.2025.07.012_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"issue":"18","key":"10.1016\/j.jaccao.2025.07.012_bib15","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jaccao.2025.07.012_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-021-00480-w","article-title":"Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies","volume":"11","author":"Rognvaldsson","year":"2021","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.jaccao.2025.07.012_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"10.1016\/j.jaccao.2025.07.012_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2023-188547","article-title":"Revised definition of free light chains in serum and light chain monoclonal gammopathy of undetermined significance: results of the iStopMM study","volume":"142","author":"Long","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaccao.2025.07.012_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.jaccao.2025.07.012_bib20","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2025.07.012_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjcard.2022.06.064","article-title":"Light chain testing abnormalities among patients with transthyretin amyloid cardiomyopathy referred for technetium-99m pyrophosphate imaging","volume":"181","author":"Alreshq","year":"2022","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.jaccao.2025.07.012_bib22","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","article-title":"Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis","volume":"44","author":"Rauf","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jaccao.2025.07.012_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clml.2022.12.012","article-title":"Monoclonal gammopathy of undetermined significance in patients with transthyretin amyloidosis (ATTR): analysis using the iStopMM criteria","volume":"23","author":"Lewis","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaccao.2025.07.012_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol"},{"issue":"14","key":"10.1016\/j.jaccao.2025.07.012_bib25","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fernandez de Larrea","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaccao.2025.07.012_bib26","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2011-07-365510","article-title":"Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue","volume":"119","author":"Brambilla","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaccao.2025.07.012_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/13506129.2021.1994386","article-title":"Tissue biopsy for the diagnosis of amyloidosis: experience from some centres","volume":"29","author":"Benson","year":"2022","journal-title":"Amyloid"},{"issue":"12","key":"10.1016\/j.jaccao.2025.07.012_bib28","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.jaccao.2025.07.012_bib29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.jaccao.2025.07.012_bib30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jacc.2024.01.010","article-title":"Histological typing in patients with cardiac amyloidosis: JACC review topic of the week","volume":"83","author":"Gonzalez-Lopez","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jaccao.2025.07.012_bib31","doi-asserted-by":"crossref","first-page":"E2403","DOI":"10.1002\/humu.22619","article-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations","volume":"35","author":"Rowczenio","year":"2014","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.jaccao.2025.07.012_bib32","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/j.gastro.2004.03.003","article-title":"Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families","volume":"126","author":"Obici","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jaccao.2025.07.012_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ki.2014.389","article-title":"Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis","volume":"87","author":"Gregorini","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jaccao.2025.07.012_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCULATIONAHA.124.072460","article-title":"AL or ATTR amyloidosis? Never two without three","volume":"151","author":"Nuvolone","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jaccao.2025.07.012_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"issue":"S1","key":"10.1016\/j.jaccao.2025.07.012_bib36","first-page":"48","article-title":"Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion","volume":"17","author":"Gertz","year":"2010","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.jaccao.2025.07.012_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jaccao.2025.07.012_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jaccao.2025.07.012_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.24772","article-title":"The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic","volume":"92","author":"Milani","year":"2017","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.jaccao.2025.07.012_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.2023022399","article-title":"Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis","volume":"143","author":"Bomsztyk","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaccao.2025.07.012_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-021-00428-0","article-title":"Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis","volume":"11","author":"Palladini","year":"2021","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.jaccao.2025.07.012_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41408-021-00511-6","article-title":"Detection of minimal residual disease by next generation sequencing in AL amyloidosis","volume":"11","author":"Sarosiek","year":"2021","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.jaccao.2025.07.012_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1182\/bloodadvances.2019001331","article-title":"Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis","volume":"4","author":"Staron","year":"2020","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jaccao.2025.07.012_bib44","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1002\/ajh.26684","article-title":"Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies","volume":"97","author":"Cascino","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jaccao.2025.07.012_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-022-10247-5","article-title":"Endomyocardial biopsy in the clinical context: current indications and challenging scenarios","volume":"28","author":"Porcari","year":"2023","journal-title":"Heart Fail Rev"},{"issue":"17","key":"10.1016\/j.jaccao.2025.07.012_bib46","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jaccao.2025.07.012_bib47","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jaccao.2025.07.012_bib48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"10.1016\/j.jaccao.2025.07.012_bib49","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:36:21Z","timestamp":1778916981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087325002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666087325002959"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.07.012","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}